You are here

UTIs

VenatoRx initiates enrollment in phase 3 trial of cefepime/VNRX-5133 in cUTIs

Pharmaceutical Business Review

Fri, 08/30/19 - 01:05 pm

clinical trials

complicated urinary tract infections

Merck's combination antibiotic scores FDA approval for urinary tract and abdominal infections

Endpoints

Wed, 07/17/19 - 09:46 am

intra-abdominal infections

Nearing phase 3, resTORbio posts new data on infection drug

Fierce Biotech

Tue, 10/16/18 - 09:46 am

respiratory infections

It's a good news, bad news FDA approval for Achaogen's powerful antibiotic Zemdri

Fierce Pharma

Wed, 06/27/18 - 10:18 am

Achaogen's stock rockets after positive UTI drug trial results

Marketwatch

Tue, 12/13/16 - 01:22 pm

clinical trials

Pages